DB17718ExperimentalNucleic Acid Based Therapies
mRNA-3351 is a modified mRNA encoding the UGT1A1 gene. Developed by Moderna, it is currently being investigated as the treatment for Crigler-Najjar syndrome.
- Code names
- mRNA-3351
Which companies are running trials of mRNA-3351, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account